Genetically Modified Salmon in Aquaculture: Well Regulated and Safe

A Massachusetts company, Aquabounty Technologies, submitted an application to the U.S. Food and Drug Administration (FDA) in 1995 to grow a genetically modified AquAdvantage® Atlantic salmon to be marketed as a food product. Aquabounty proposed to raise the broodstock fish on Prince Edward Island, ship their eggs to a contained inland recirculating production system in Panama to grow, harvest and process the fish, and then ship food grade product back to the United States for sale. The fish for this physically secure production system would be at least 99 percent triploid and all-female, as an additional reproductive-containment measure.